Episode Details

Kevin Church, Chief Science Officer of Athira Pharma, joins Suzanne to talk about what happens in clinical trials, how long do they last, and what the different types are.

There are 143 Alzheimer's treatments in various stages of study at the moment, including those in clinical trials stage 1, 2, and 4. Athira's trials last about six months long. They involve periodic visits to a trial center, usually a hospital, meeting monthly or bimonthly over the course of the study, while being given either the treatment or a placebo. The patient's caregiver is essential to the trial.

If you're a caregiver or an adult child, if you're interested in participating in a clinical trial, talk to a specialist to see if it's appropriate. Talk to your doctor or neurologist, or a specialist at a clinic — visit clinicaltrials.gov for trials in your area, and the LIFT-AD Clinical Trial website for Athira Pharma's trials. See AFE's Alzheimer's and Dementia page and AFE's Athira Pharma podcasts page for more shows about these topics. Courtesy of Athira Pharma.

See omnystudio.com/listener for privacy information.